The James Buchanan Brady Urological Institute
 
 
 
Channing J. Paller, M.D. Channing J. Paller, M.D.
Assistant Professor of Oncology
Sidney Kimmel Comprehensive Cancer Center
Faculty Director, Specimen Accessioning Core
Sibley Memorial Hospital, Washington, DC.

Email:cpaller1@jhmi.edu
 

Free Access to abstracts at PubMed

Publications

  1. Somjen, D., Paller, C., Gayer, B., Kohen, F., Knoll, E. and Stern, N. High glucose blocks estradiol's effects on human vascular cell growth: differential interaction with estradiol and raloxifene. Journal of Steroid Biochemistry and Molecular Biology. 2004; 88:101-110. PMCID: 3638755.

  2. Paller CJ, Shiels MS, Rohrmann S, Basaria S, Rifai N, Nelson W, Platz EA, Dobs A. Relationship of sex steroid hormones with bone mineral density (BMD) in a nationally representative sample of men Clinical endocrinology. 2009;(1):26-34. PMCID: 3494466.

  3. Paller C., Campbell, C., Edwards, R., Dobs A. Sex-based differences in pain perception and treatment. Pain Medicine. 2009 Mar;10(2):289-99. PMCID: 2745644.

  4. Paller CJ, Rudin CM. Youth has no age: cancer treatment for older Americans. Oncology (Williston Park, N.Y.). 2010 Nov 15;24(12):1114, 1118, 1120. PMCID: 3482117.

  5. Paller CJ, Antonarakis ES. Cabazitaxel: a novel second-line treatment for metastatic castration-resistant prostate cancer. Drug design, development and therapy. 2011 Mar 10;5:117-24. PMCID: 3063116.

  6. Paller, C., Ye, X, Wozniak, P., Gillespie, B., Sieber, P., Greengold, R., Stockton, B., Hertzman, B., Efros, M., Roper, R., Liker, H., Carducci, M.. A phase II study of pomegranate extract for men with rising prostate specific antigen following primary therapy. Prostate Cancer and Prostatic Diseases. 2013 March; PMCID: 3549301.

  7. Paller CJ, Antonarakis ES. Sipuleucel-T for the treatment of metastatic prostate cancer: promise and challenges. Human vaccines and immunotherapeutics. 2012;8(4):509-19.

  8. Paller CJ, Smith TJ. Finasteride and prostate cancer: a commentary. The Oncologist. 2012;17(7):888-90. PMCID: 3399642.

  9. Paller CJ, Shiels MS, Rohrmann S, Menke A, Rifai N, Nelson WG, Platz EA, Dobs AS. Association between Sex Steroid Hormones and Hematocrit in a Nationally-Representative Sample of Men. Journal of Andrology. 2012 Nov-Dec; 33(6): 1332-41. PMCID: 3774012.

  10. Paller CJ, Carducci MA, Philips GK. Management of bone metastases in refractory prostate cancer - role of denosumab. Clinical interventions in aging. 2012;7:363-72. PMCID: 3459574.

  11. Paller CJ, Antonarakis ES. Management of biochemically recurrent prostate cancer after local therapy: evolving standards of care and new directions. Clinical advances in hematology and oncology: H&O. 2013 Jan;11(1):14-23. PMCID: 3624708.

  12. Paller CJ., Antonarakis EA., Eisenberger M., Carducci, Management of patients with biochemical recurrence after local therapy for prostate cancer in Hematology/Oncology.  Clinical Advances in Hematology and Oncology. 2013 Jan;11(1):14-23.  PMCID:  3624708.

  13. Paller CJ, Ye X, Wozniak PJ, Gillespie BK, Sieber PR, Greengold RH, Stockton BR, Hertzman BL, Efros MD, Roper RP, Liker HR, Carducci MA.  A randomized phase II study of pomegranate extract for men with rising PSA following initial therapy for localized prostate cancer.  Prostate Cancer Prostatic Dis. 2013 Marc;16(1):50-5. PMCID: 3549301.

 



© The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System. All rights reserved.| Disclaimer
Email: webmaster@urology.jhu.edu | 600 North Wolfe Street, Baltimore, Maryland 21287